Valeant Pharmaceuticals International Inc $124.62

up +2.08


23/7/2014 04:01 PM  |  NYSE : VRX  
Industries : Drugs / Drug Delivery & Accessories
Get Trend Analysis Icon Get VRX Trend Analysis - it has outperformed the S&P 500 by 16%

Partner Headlines

  1. BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share

    Benzinga
  2. Allergan EPS Gains Accelerate

    IBD
  3. Allergan Earnings Growth, Job Cuts Counter Valeant

    IBD
  4. UPDATE: Valeant Complains to SEC Regarding Allergan Claims

    Benzinga
  5. Valeant Submits HSR Filing Related to Proposed Allergan Deal

    Benzinga
  6. Benzinga's M&A Chatter for Wednesday July 9, 2014

    Benzinga
  7. Aegis Capital Believes Valeant Pharmaceuticals' Bid For Allergan Is Looking ...

    Benzinga
  8. Chipotle, Keurig Near Buy Points; Energy Dominates

    IBD
  9. Auxilium Acquiring QLT For New Products, Low Taxes

    IBD
  10. Benzinga's M&A Chatter for Wednesday June 25, 2014

    Benzinga
  11. Paulson builds Allergan stake

    IBD
  12. Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

    Benzinga
  13. Markets Close Higher Despite A Contraction In GDP

    Benzinga
  14. Benzinga's M&A Chatter for Tuesday June 24, 2014

    Benzinga
  15. Indexes Mixed As Stocks Pare Earlier Gains

    IBD
  16. Walgreen Falls On Weak Earnings, Alliance Boots Reset

    IBD
  17. 'Merger Monday' Deals, Offers And Rejections

    Benzinga
  18. Allergan Rebuffs Valeant's Tender Offer

    FoxBusiness
  19. Akorn

    IBD
  20. Akorn Shares Gaining On $41 Million Sale Of Branded Drugs Unit To Valeant

    Benzinga
  21. Shire Rejects AbbVie's $46 Bil Tax-Inversion Attempt

    IBD
  22. Valeant launches hostile bid

    IBD
  23. M&A Activity Helps Fuel Healthy Action In Drugmakers

    IBD
  24. Benzinga's M&A Chatter for Wednesday June 18, 2014

    Benzinga
  25. 5-Star Biotech Stock Watch: Synta Pharmaceuticals

    Benzinga
  26. Stocks Meander As Fed Announcement Looms

    IBD
  27. Air Products Soars As CEO Pick Suggests Asset Sales

    IBD
  28. Valeant Goes For Allergan; Analyst Touts Shire Option

    IBD
  29. Allergan, Actavis Top Big Cap Pharmas Amid M&A Flurry

    IBD
  30. Valeant shifts takeover tactics

    IBD
  31. Global M&A Up 73% To $1.6 Trillion; Health, Media Top

    IBD
  32. Valeant Pharmaceuticals

    IBD
  33. Shire Up On Report It Proactively Hired Investment Bank

    Benzinga
  34. Allergan rebuffs Valeant again

    IBD
  35. Benzinga's M&A Chatter for Tuesday June 10, 2014

    Benzinga
  36. Major Averages Fall Modestly; Facebook Bucks Trend

    IBD
  37. Stocks Hold Mild Losses; B/E Aerospace Slides

    IBD
  38. Allergan Turns Down Valeant Bid

    FoxBusiness
  39. Valeant Pharma

    IBD
  40. Ackman Explains Valeant Bid, Makes Up with Carl Icahn

    GuruFocus
  41. Several IBD 50 Names Set Up In Stock Picker's Market

    IBD
  42. Allergan May Get Higher Bid

    IBD
  43. Valeant Plans to Improve Offer for Allergan

    FoxBusiness
  44. Valeant Pharmaceuticals Responds to Allergan's Rejection of Merger Proposal

    Benzinga
  45. Allergan Rejects Valeant Bid

    IBD
  46. Benzinga's M&A Chatter for Monday May 12, 2014

    Benzinga
  47. Valeant Stock Moves Little As Takeover Bid Rejected

    IBD
  48. Leaderboard Is Educational, Informative, Actionable

    IBD
  49. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  50. Indexes Surge In Light Volume; Allergan Shuns Valeant

    IBD
Trading Center